Hikma Pharmaceutical | HIK - Loan Capital



Hikma Pharmaceutical reported $607M in Loan Capital for its fiscal semester ending in December of 2024.


Loan Capital Change Date
Almirall EUR 365.88M 24.38M Jun/2025
argenx SE 35.57M 32.76M Jun/2025
AstraZeneca USD 25.99B 1.9B Jun/2025
Autolus Therapeutics Ltd 244.63M 8.81M Jun/2025
Bayer EUR 31.71B 3.31B Jun/2025
Fresenius EUR 9.31B 2.08B Jun/2025
Galapagos EUR 6.05M 1.74M Jun/2025
Genmab DKK 132M 3M Jun/2025
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
GRIFOLS EUR 7.45B 1.94B Jun/2025
Hikma Pharmaceutical USD 607M 454M Dec/2024
Lonza CHF 4.24B 602M Dec/2024
Merck EUR 6.3B 665M Jun/2025
Orion EUR 136M 154.8M Jun/2025
Recordati EUR 2.09B 37.29M Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
Sanofi 13.2B 211M Jun/2025
UCB EUR 2.96B 21M Dec/2024